NEW CANCER VAX KILLS TUMORS!
AREVOLUTIONARY personalized cancer vaccine — designed to harness a patient’s own immune system and exhibit only mild side effects — may be the long-awaited cure for the killer disease, experts say.
Researcher Dr. Thomas Wagner developed the tumor lysate particle only (TLPO) jab amid his search for a treatment without the notorious problems associated with chemotherapy — such as hair loss, nausea, vomiting and low white blood cell count, which leaves folks in danger of life-threatening bugs.
“The tragedy of cancer is not just that person, the diagnosis, but it’s also the fear of the therapy,” the doc explains.
Malignant cells evade the immune system because they’re recognized as part of the body. But Wagner says TLPO uses tumor samples to identify the rogue cells, and after they’re presented back into the body via injection, the therapy stimulates the immune system to detect cancer and eliminate it — as if it’s an infection!
The vaccine was most recently tested in hundreds of subjects with advanced skin cancer. About 68 percent of stage 4 patients who underwent the treatment experienced three years of diseasefree survival, but that number plummeted to zero in the placebo group!
The reported side effects included redness or pain at the injection site, as well as fever and fatigue.
The Food and Drug Administration has given the green light to Wagner’s vax for a phase 3 clinical trial to compare its safety and efficacy against current therapies, which is considered the final hurdle toward approval.
The 36-month project — which is slated to enroll 500 individuals, including those with solid tumor cancers, in the brain, lungs and breasts — may launch as soon as this year.